Medtronic CEO: Our Pipeline Has Never Been Stronger

Medtronic CEO Omar Ishrak wasn’t shy about touting the company’s growth drivers during the company’s first-quarter 2019 earnings call Monday.

Medtronic executives were upbeat about the company’s fiscal first-quarter 2019 results Monday, and for good reason. The company beat analyst expectations on both earnings and revenue and offered a positive outlook for the back half of the year.

“We are executing on the strongest pipeline in Medtronic’s nearly 70-year history,” CEO Omar Ishrak said during the earnings call, as transcribed by SeekingAlpha. Later he reiterated that sentiment in response to an analyst’s question, “Our pipeline has never been stronger.”

One area of interest, in particular, is the company’s diabetes group, which had the best quarterly performance in more than a decade with 26.3% growth driven by sustained strong demand for the MiniMed 670G hybrid closed-loop system. Ishrak said the company now has more than 97,000 trained active users of the 670G system. Outside of the United States, Medtronic is just now beginning to sell the 670G in international markets.

In standalone continuous glucose monitoring (CGM), the launch of the Guardian Connect with the Sugar.IQ assistant is off to a solid start, Ishrak said, taking share in the $1 billion CGM market.

“With the Sugar.IQ assistant, Guardian Connect is the only Smart CGM using the cognitive computing capability of IBM Watson to give personalized insights and predictive alerts. The higher CGM sensor attachment and utilization that we are seeing with integrated pump users combined with the sensors that are used with Guardian Connect are not only driving strong CGM sales growth, which was nearly 15% this quarter but also creating a consistent long-term annuity stream for our diabetes group,” Ishrak said.

By Amanda Pedersen | MD+DI

Image Credit: Medtronic

READ MORE

About Peter Coffaro 524 Articles
A growth-driven and strategic executive, Peter Coffaro commands more than 20 years of progressive management success within the medical device industry. As a District Sales Manager for Stryker Orthopaedics, Peter was responsible for managing and directing a regional sales force to achieve sales and profit goals within the Rocky Mountain region. Previously, he was the Director of Sales & Marketing for Amp Orthopedics. In this role, Peter was responsible for planning, developing, and leading all sales and marketing initiatives. Peter is a former orthopedic distributor in the Pacific Northwest. He has also worked with DePuy Orthopaedics as well as Zimmer, and held positions in sales, sales training, and sales management. Peter has an extensive background in organizational development, business development, sales management, negotiating and P&L management. Peter holds a B.S. degree in Biology from Northern Illinois University.

Be the first to comment

Leave a Reply

Your email address will not be published.


*


This site uses Akismet to reduce spam. Learn how your comment data is processed.